A software glitch in a mobile app used in conjunction with an insulin pump prompted a recall after 224 individuals throughout the United States were injured. No deaths have been reported.
The U.S. Food and Drug Administration (FDA) reported that the 2.7 version of the Apple iOS t:connect mobile app, which is used with the t:slim X2 insulin pump with Control-IQ technology, is under a Class 1 recall, the most serious recall, as the device’s use could result in injury or death.





